Unibest
← Back to patent-cliff list

Irbesartan

Tier B — Position early

Irbesartan

Sanofi
Originator
1997
First approval
-
Expiry (public)
$2.25B ▲
Peak sales
Small molecule
Type

Targets:AT1

Brand:Karvea, Irbetan, Aprovel/Avapro, Aprovel/Karvea/Avapro, Avapro, Aprovel

Indications (approved):Oesophageal disease, Hypertension, Diabetic nephropathy

Regional status

US
Approved
1997-09-30
EU
Approved
1997-08-26
China
Approved
2013-03-19
Japan
Approved
2008-04-16

Factories producing this API1

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

1 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates5 routes

Originator routes × 1Optimised (non-patent) × 4Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield 1.42 g
IRBE-0011664-35-3IRBE-002999-09-7IRBE-003138402-05-8IRBE-004114772-54-2IRBE-005138401-24-8IRBE-00657598-33-1IRBE-0074294-57-9IRBE-00884392-32-5IRBE-009114772-53-1API · Irbesartan
CodeCAS No.Intermediate
IRBE-0011664-35-3ethyl 1-aminocyclopentane-1-carboxylate
IRBE-002999-09-7ethyl pentanimidate
IRBE-003138402-05-8Available2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
IRBE-004114772-54-24'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile
IRBE-005138401-24-84'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile
IRBE-00657598-33-12-(2-methoxyphenyl)-4,4-dimethyl-4,5-dihydrooxazole
IRBE-0074294-57-9p-tolylmagnesium bromide
IRBE-00884392-32-54,4-dimethyl-2-(4'-methyl-[1,1'-biphenyl]-2-yl)-4,5-dihydrooxazole
IRBE-009114772-53-14'-methyl-[1,1'-biphenyl]-2-carbonitrile
OptimisedRoute 2Steps 5 · Total yield 380.00 mg
IRBE-010106-37-6IRBE-0111122-91-4IRBE-012873-75-6IRBE-013589-15-1IRBE-014151257-01-1IRBE-015731851-41-5IRBE-016144873-97-2API · Irbesartan
CodeCAS No.Intermediate
IRBE-010106-37-6Available1,4-dibromobenzene
IRBE-0111122-91-44-bromobenzaldehyde
IRBE-012873-75-6(4-bromophenyl)methanol
IRBE-013589-15-11-bromo-4-(bromomethyl)benzene
IRBE-014151257-01-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride
IRBE-015731851-41-53-(4-bromobenzyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
IRBE-016144873-97-2(2-(1-trityl-1H-tetrazol-5-yl)phenyl)boronic acid
OptimisedRoute 3Steps 3 · Total yield 1.83 g
IRBE-01715026-80-9IRBE-01859528-27-7IRBE-019908117-90-8IRBE-020908227-87-2IRBE-021155884-01-8API · Irbesartan
CodeCAS No.Intermediate
IRBE-01715026-80-91-pentanamidocyclopentane-1-carboxylic acid
IRBE-01859528-27-7(4-iodophenyl)methanamine hydrochloride
IRBE-019908117-90-8N-(4-iodobenzyl)-1-pentanamidocyclopentane-1-carboxamide
IRBE-020908227-87-22-butyl-3-(4-iodobenzyl)-1,3-diazaspiro[4.4]non-1-en-4-one
IRBE-021155884-01-8(2-(1H-tetrazol-5-yl)phenyl)boronic acid
OptimisedRoute 4Steps 4 · Total yield 1.05 g
IRBE-004114772-54-2IRBE-005138401-24-8IRBE-02217193-28-1IRBE-023638-29-9IRBE-024177219-40-8IRBE-025141745-71-3API · Irbesartan
CodeCAS No.Intermediate
IRBE-004114772-54-24'-(bromomethyl)-[1,1'-biphenyl]-2-carbonitrile
IRBE-005138401-24-84'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile
IRBE-02217193-28-11-aminocyclopentane-1-carboxamide
IRBE-023638-29-9pentanoyl chloride
IRBE-024177219-40-81-pentanamidocyclopentane-1-carboxamide
IRBE-025141745-71-3N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentane-1-carboxamide
OptimisedRoute 5Steps 5 · Total yield /
IRBE-005138401-24-8IRBE-01715026-80-9IRBE-023638-29-9IRBE-026120-92-3IRBE-02749830-37-7IRBE-02892398-48-6IRBE-029133690-92-3API · Irbesartan
CodeCAS No.Intermediate
IRBE-005138401-24-84'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile
IRBE-01715026-80-91-pentanamidocyclopentane-1-carboxylic acid
IRBE-023638-29-9pentanoyl chloride
IRBE-026120-92-3cyclopentanone
IRBE-02749830-37-71-aminocyclopentane-1-carbonitrile
IRBE-02892398-48-61-aminocyclopentane-1-carboxylic acid hydrochloride
IRBE-029133690-92-34'-(aminomethyl)-[1,1'-biphenyl]-2-carbonitrile

Frequently asked questions

What are the approved indications of Irbesartan?

Approved indications include: Oesophageal disease, Hypertension, Diabetic nephropathy.

When does the Irbesartan patent expire?

No public expiry year is available for Irbesartan yet; this page updates once verified.

How many synthesis routes are recorded for Irbesartan?

5 synthesis routes are recorded; the shortest is 3 steps with 1.83 g total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Irbesartan intermediates?

2 intermediate CAS of Irbesartan are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.

How do I get a quote for Irbesartan intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29